In addition to influencing factors such as tumor stage, subgroups, and risk level grading, FOXO1 fusion positivity, age less than 1 year, age greater than 10 years, and TP53 mutations are poor prognostic factors (25–29). The gene discussed is TP53; the disease is neoplasm.